Therapeutic efficacy of interferon of HCV-RNA in chronic hepatitis C

Greenberg HB, Lindberg J, Lundin P, et al: Effect of human leukocyte interferon on hepatitis B viral infection in patients with chronic active hepatitis. N Engl J Med 1976 ;295:517–522 Kuroki, T, Nishiguchi S, Saito S, et al: Response of 2′,5′-oligoadenylate synthetase in hepatitis Be antigen-positive chronic hepatitis B treated with interfreon. New trend in peptic ulcer and hepatitis. Part II Chronic Hepatitis Excerpta Medica, Tokyo 1986;115–120 Kuroki T, Nishiguchi S, Takeda T, et al: Studies on the relation between response of 2′,5′-oligadenylate synthetase and efficacy of interferon therapy in chronic hepatitis B. New trend in hepatology. Excerpta Medica, Tokyo 1986;249–255 Nishiguchi S, Kuroki T, Otani S, et al: Relationship of the effects of interferon on chronic hepatitis B and the induction of 2′,5′oligoadenylate synthetase. Hepatology 1989;10:29–33 Nakajima S, Kuroki T, Shintani M, et al: Changes in interferon receptor on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon. Hepatology 1990:12:1261–1265 Hoofnagle JH, Mullen KD, Joncs DB, et al: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986;315:1575–1578 Choo Q-L, Kuo G, Weiner AJ. et al: Isolation of cDNA clone derived from a blood -borne non-A, non-B viral hepatitis genome. Science 1989;244:359–362 Di Bisceglie, A.M, Martin P, Kassianides et al. Reconbinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321: 1506–1610